Titan Biotech Ltd has informed BSE that a meeting of the Board of Directors of the company will be held on 30th May, 2016 for considering Audited Financial Results of the Company for the financial year ended 31st March, 2016 and recommendation of dividend.
Further, the trading window of the Company will remain closed for designated persons from date of notice to 1st June, 2016.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
